These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 22000408)

  • 1. Guillain-Barré syndrome associated with the D222E variant of the 2009 pandemic influenza A (H1N1) virus: case report and review of the literature.
    Cortese A; Baldanti F; Tavazzi E; Carnevale L; Minoli L; Lozza A; Marchioni E
    J Neurol Sci; 2012 Jan; 312(1-2):173-6. PubMed ID: 22000408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(21):657-61. PubMed ID: 20520590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guillain-Barre syndrome, influenzalike illnesses, and influenza vaccination during seasons with and without circulating A/H1N1 viruses.
    Grimaldi-Bensouda L; Alpérovitch A; Besson G; Vial C; Cuisset JM; Papeix C; Lyon-Caen O; Benichou J; Rossignol M;
    Am J Epidemiol; 2011 Aug; 174(3):326-35. PubMed ID: 21652600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pandemic influenza A vaccination and incidence of Guillain-Barré syndrome in Korea.
    Kim C; Rhie S; Suh M; Kang DR; Choi YJ; Bae GR; Choi YC; Jun BY; Lee JS
    Vaccine; 2015 Apr; 33(15):1815-23. PubMed ID: 25728315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.
    Salmon DA; Proschan M; Forshee R; Gargiullo P; Bleser W; Burwen DR; Cunningham F; Garman P; Greene SK; Lee GM; Vellozzi C; Yih WK; Gellin B; Lurie N;
    Lancet; 2013 Apr; 381(9876):1461-8. PubMed ID: 23498095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pandemic A/H1N1 2009 influenza vaccination, preceding infections and clinical findings in UK children with Guillain-Barré syndrome.
    Verity C; Stellitano L; Winstone AM; Stowe J; Andrews N; Miller E
    Arch Dis Child; 2014 Jun; 99(6):532-8. PubMed ID: 24585755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Guillain-Barré syndrome after exposure to pandemic influenza A(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study.
    Ghaderi S; Gunnes N; Bakken IJ; Magnus P; Trogstad L; Håberg SE
    Eur J Epidemiol; 2016 Jan; 31(1):67-72. PubMed ID: 26008750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guillain-Barré syndrome after exposure to influenza virus.
    Lehmann HC; Hartung HP; Kieseier BC; Hughes RA
    Lancet Infect Dis; 2010 Sep; 10(9):643-51. PubMed ID: 20797646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guillain-Barré syndrome and influenza virus infection.
    Sivadon-Tardy V; Orlikowski D; Porcher R; Sharshar T; Durand MC; Enouf V; Rozenberg F; Caudie C; Annane D; van der Werf S; Lebon P; Raphaël JC; Gaillard JL; Gault E
    Clin Infect Dis; 2009 Jan; 48(1):48-56. PubMed ID: 19025491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guillain-Barré syndrome after H1N1 vaccination in the United States: a report using the CDC/FDA Vaccine Adverse Event Reporting System (2009).
    Souayah N; Yacoub HA; Khan HM; Michas-Martin PA; Menkes DL; Maybodi L; Qureshi AI
    Neuroepidemiology; 2012; 38(4):227-32. PubMed ID: 22555646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical forms of Guillain-Barré syndrome and H1N1-influenza vaccination.
    Shaikh AG; Termsarasab P; Nwankwo C; Rao-Frisch A; Katirji B
    Vaccine; 2012 May; 30(22):3251-4. PubMed ID: 22429755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-ganglioside antibodies were not detected in human subjects infected with or vaccinated against 2009 pandemic influenza A (H1N1) virus.
    Lei T; Siu KL; Kok KH; Chan KH; Chan EY; Hung IF; To KK; Li PC; Zhou J; Zheng BJ; Yuen KY; Wang M; Jin DY
    Vaccine; 2012 Mar; 30(16):2605-10. PubMed ID: 22342549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of Guillain-Barré syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009-2010 seasonal influenza vaccines: results from self-controlled analyses.
    Tokars JI; Lewis P; DeStefano F; Wise M; Viray M; Morgan O; Gargiullo P; Vellozzi C
    Pharmacoepidemiol Drug Saf; 2012 May; 21(5):546-52. PubMed ID: 22407672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chart-confirmed guillain-barre syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009-2010.
    Polakowski LL; Sandhu SK; Martin DB; Ball R; Macurdy TE; Franks RL; Gibbs JM; Kropp GF; Avagyan A; Kelman JA; Worrall CM; Sun G; Kliman RE; Burwen DR
    Am J Epidemiol; 2013 Sep; 178(6):962-73. PubMed ID: 23652165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A population-based study of neurologic manifestations of severe influenza A(H1N1)pdm09 in California.
    Glaser CA; Winter K; DuBray K; Harriman K; Uyeki TM; Sejvar J; Gilliam S; Louie JK
    Clin Infect Dis; 2012 Aug; 55(4):514-20. PubMed ID: 22573853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guillain-Barré syndrome following H1N1 immunization in a pediatric patient.
    Tremblay ME; Closon A; D'Anjou G; Bussières JF
    Ann Pharmacother; 2010; 44(7-8):1330-3. PubMed ID: 20484170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guillain-Barré syndrome following the 2009 pandemic monovalent and seasonal trivalent influenza vaccination campaigns in Spain from 2009 to 2011: outcomes from active surveillance by a neurologist network, and records from a country-wide hospital discharge database.
    Alcalde-Cabero E; Almazán-Isla J; García López FJ; Ara-Callizo JR; Avellanal F; Casasnovas C; Cemillán C; Cuadrado JI; Duarte J; Fernández-Pérez MD; Fernández Ó; Merino JA; Montero RG; Montero D; Pardo J; Rodríguez-Rivera FJ; Ruiz-Tovar M; de Pedro-Cuesta J;
    BMC Neurol; 2016 May; 16():75. PubMed ID: 27206524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substitutions in position 222 of haemagglutinin of pandemic influenza A (H1N1) 2009 viruses in Spain.
    Ledesma J; Pozo F; Pérez Ruiz M; Navarro JM; Piñeiro L; Montes M; Pérez Castro S; Suárez Fernández J; García Costa J; Fernández M; Galán JC; Cuevas MT; Casas I; Pérez Breña P;
    J Clin Virol; 2011 May; 51(1):75-8. PubMed ID: 21353628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guillain-Barré syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case series.
    Crawford NW; Cheng A; Andrews N; Charles PG; Clothier HJ; Day B; Day T; Gates P; Macdonell R; Roberts L; Rodriguez-Casero V; Wijeratne T; Kiers L
    Med J Aust; 2012 Nov; 197(10):574-8. PubMed ID: 23163689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence.
    Vellozzi C; Iqbal S; Broder K
    Clin Infect Dis; 2014 Apr; 58(8):1149-55. PubMed ID: 24415636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.